118 related articles for article (PubMed ID: 11168124)
1. The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Adamsson I; Edlund C; Seensalu R; Engstrand L
Clin Microbiol Infect; 2000 May; 6(5):265-7. PubMed ID: 11168124
[No Abstract] [Full Text] [Related]
2. OAM for cure of Helicobacter pylori infection.
Savarino V; Mansi C; Vigneri S
Aliment Pharmacol Ther; 2000 Aug; 14(8):1103-4. PubMed ID: 10930908
[No Abstract] [Full Text] [Related]
3. [The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin].
Rodrigo Sáez L; Fernández Cadenas F; Lomo Montero J; García Calero C; García Saavedra L
Rev Esp Enferm Dig; 1997 Feb; 89(2):146-7. PubMed ID: 9115827
[No Abstract] [Full Text] [Related]
4. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
5. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
6. Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient.
Furuta T; Takashima M; Shirai N; Xiao F; Hanai H; Ohashi K; Ishizaki T
Clin Pharmacol Ther; 2000 Jun; 67(6):684-9. PubMed ID: 10872651
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Helicobacter pylori infections].
Calvet Calvo X
Gastroenterol Hepatol; 1998 Apr; 21(4):203-6. PubMed ID: 9633184
[No Abstract] [Full Text] [Related]
8. [Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Piqué JM
Med Clin (Barc); 2000 Jun; 115(1):23-4. PubMed ID: 10953833
[No Abstract] [Full Text] [Related]
9. PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial.
Stone GG; Shortridge D; Flamm RK; Beyer J; Ghoneim AT; Tanaka SK
J Antimicrob Chemother; 1997 Aug; 40(2):251-6. PubMed ID: 9301991
[TBL] [Abstract][Full Text] [Related]
10. [Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Gisbert JP; Boixeda D; Martín de Argila C
Med Clin (Barc); 1998 Nov; 111(18):716. PubMed ID: 9887438
[No Abstract] [Full Text] [Related]
11. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Houben MH; Hensen EF; Rauws EA; Hulst RW; Hoff BW; Ende AV; Kate FJ; Tytgat GN
Aliment Pharmacol Ther; 1999 Jul; 13(7):883-9. PubMed ID: 10383522
[TBL] [Abstract][Full Text] [Related]
12. Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?
Moayyedi P
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):506-8. PubMed ID: 9513823
[No Abstract] [Full Text] [Related]
13. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Helicobacter pylori infection].
Lamouliatte H; Cayla R; Mégraud F
Rev Prat; 2000 Sep; 50(13):1442-5. PubMed ID: 11019637
[TBL] [Abstract][Full Text] [Related]
15. [Sequential therapy regimen for Helicobacter pylori infection in children].
Kalach N; Serhal L; Bergeret M; Spyckerelle C; Dupont C; Raymond J
Arch Pediatr; 2008 Feb; 15(2):200-1. PubMed ID: 18249101
[No Abstract] [Full Text] [Related]
16. A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Laurent J; Mégraud F; Fléjou JF; Caekaert A; Barthélemy P
Aliment Pharmacol Ther; 2001 Nov; 15(11):1787-93. PubMed ID: 11683693
[TBL] [Abstract][Full Text] [Related]
17. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
18. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Fennerty MB
Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
[No Abstract] [Full Text] [Related]
19. High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
Isomoto H; Inoue K; Furusu H; Enjoji A; Fujimoto C; Yamakawa M; Hirakata Y; Omagari K; Mizuta Y; Murase K; Shimada S; Murata I; Kohno S
Aliment Pharmacol Ther; 2003 Jul; 18(1):101-7. PubMed ID: 12848631
[TBL] [Abstract][Full Text] [Related]
20. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
